Zeaxanthin Trade Association   Home Contact Us

Vision Facts

  • Age-Related Macular Degeneration (AMD) is a disease associated with aging that gradually destroys sharp, central vision. Central vision is needed for seeing objects clearly and for common daily tasks, such as reading and driving.
  • Age-Related Macular Degeneration is the leading cause of blindness in Americans over the age of 55.
  • As Baby Boomers age, 14 to 24 percent of the U.S. population age 65 to 74 will have Age-Related Macular Degeneration.
  • Dry AMD has three stages: Early AMD, Intermediate AMD and Advanced Dry AMD.
  • The Lewin Study estimates that daily intake of six to 10 mg/day of lutein and Zeaxanthin could save Medicare $3.6 billion over five years by helping people with AMD avoid the transition to dependence.
  • Cataracts are the leading cause of blindness worldwide and are one of the most costly diseases to treat in the Federal Medicare Budget.
  • Over 17 million elderly Americans have early signs of Age-Related Macular Degeneration.
  • The cost for AMD medical therapies in the U.S. can reach $24,000 per person per year.
  • Seventy-five percent of the U.S. general population is concerned about preventing vision problems.
  • Nearly 10 percent of adults in the U.S. said they have some sort of vision problem.
  • Eye health ranks 4th among Americans as an important health concern, with 47 percent stating that they would rank it as a primary concern.
  ©2012 Zeaxanthin Trade Association   |   622 Town Road, West Chicago, IL 60185-2698   |   USA   |   Phone: ???-000-000   |   Fax: ???-000-0000   Design by Image Perspective